Illumina offers technologies designed to make genomic analysis accessible to everyone. Using powerful, proven Illumina next-generation sequencing (NGS) and microarray solutions, researchers can now read and understand genetic variations at new depths, more easily and quickly than before, enabling a wide variety of genomics applications. As a result, discoveries that were unimaginable even a few years ago are now becoming routine.
Genotyping is a popular and effective way to screen for SNPs and structural variations across the genome. Illumina technology offers accuracy, reproducibility, and flexibility with content selection.
Learn MoreIllumina technologies enable characterization of all transcriptional activity (coding and non-coding), or focusing on a select subset of RNA transcripts within a given sample for high-quality gene expression and transcriptome analysis.
Learn MoreIllumina offers a broad portfolio of simple-to-use, cost-efficient epigenetic analysis tools for studying epigenetic modifications and their impact on gene regulation.
Learn MoreNGS enables researchers to discover CRISPR genome editing off-target effects, confirm gene knockouts, and assess the functional impact of edits.
Learn MoreWith ultra-high throughput, scalability, and speed, NGS enables researchers to study biological systems at a level never before possible. Learn more about how NGS works.
Illumina offers a high-density microarray technology that increases genomic coverage for whole-genome genotyping; resolution for cytogenetics and CNV detection; and sample throughput for focused genotyping and DNA methylation. Learn more about microarray technology.
Dr. Frank Middleton uses arrays, whole-genome sequencing, and gene expression analysis to screen for alterations in schizophrenia.
All the information you need, from BeadChips to library preparation to sequencer selection and analysis. Select the best tools for your lab.
Gain insight with our webinars, scientific reviews, product introductions, and more.